Results 81 to 90 of about 96,104 (260)

Biomarkers of lung congestion and injury in acute heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 781-789, April 2025.
Abstract Acute heart failure (AHF) classification and management are primarily based on lung congestion and/or hypoperfusion. The quantification of the vascular and tissue lung damage is not standard practice though biomarkers of lung injury may play a relevant role in this context.
Marco Guazzi, Gabriele Novello, Francesca Bursi, Anna Caretti, Noemi Furlotti, Ross Arena, Paola Argiento, Julio Núñez, Antoni Bayes‐Genis, Marco Metra   +9 more
wiley   +1 more source

N-terminal pro-brain natriuretic peptide’s serum level in severe traumatic brain injury [PDF]

Archives of the Balkan Medical Union, 2018
Introduction. During the last decade, multiple studies tried to assess the correlation between brain hemorrhage and increased levels of Brain Natriuretic Peptide.
Cristina TASE GHINGULEAC, Bogdan GHINGULEAC, Rodica TUDORAN, Ileana ION   +3 more
doaj   +1 more source

Brain Natriuretic Peptide in Cirrhosis [PDF]

International Journal of Community & Family Medicine, 2016
Brain natriuretic peptide (BNP) is well known cardiac hormone released from the left ventricle myocardium as result of heart wall injury. It is a often used biochemical marker of heart failure. Its greatest role is in distinguishing etiology of dyspnea. The role of BNP in cirrhotic patients is not fully explored jet.
Bastiančić, Ana Lanca, Milić, Sandra
openaire   +1 more source

MELD score predicts outcomes in patients with advanced heart failure: A longitudinal evaluation

ESC Heart Failure, Volume 12, Issue 2, Page 839-847, April 2025.
Abstract Aims Advanced heart failure (AHF) is characterized by recurrent episodes of haemodynamic instability and frequent hospitalizations, leading to a progressive decline in quality of life and high mortality rates. The objectives of this study were to evaluate the effect of the model for end‐stage liver disease (MELD) score and its variations in ...
Francesco Curcio, Cristiano Amarelli, Rosaria Chiappetti, Irene Mattucci, Veronica Flocco, Mahmoud Issa Rammal, Ciro Abete, Francesca Mazzella, Ciro Maiello, Pasquale Abete, Francesco Cacciatore   +10 more
wiley   +1 more source

A two-centre study investigating the association between brain natriuretic peptides & outcomes in continuous flow left ventricular assist device recipients

Journal of Cardiothoracic Surgery
Background Natriuretic peptides are useful prognostic markers in patients with heart failure and this study aims to evaluate the association between N-terminal pro-brain natriuretic peptide and outcomes in patients with a continuous-flow left ventricular
Maria Lambadaris, Farid Foroutan, Julie KK Vishram-Nielsen, Marie Sophie S. Knudsen, Filio Billia, Vivek Rao, Finn Gustafsson, Ana C Alba   +7 more
doaj   +1 more source

Circulating neuregulin-1 and galectin-3 can be prognostic markers in breast cancer [PDF]

, 2017
Background: It is important to identify novel plasmatic biomarkers that can contribute to assessing the prognosis and outcome of breast cancer patients.
Cardelli, Patrizia, DE IULIIS, Francesca, Lanza, Rosina, Salerno, Gerardo, Scarpa, Susanna, Taglieri, Ludovica   +5 more
core   +1 more source

Pre-hospital management protocols and perceived difficulty in diagnosing acute heart failure [PDF]

, 2020
Aim To illustrate the pre-hospital management arsenals and protocols in different EMS units, and to estimate the perceived difficulty of diagnosing suspected acute heart failure (AHF) compared with other common pre-hospital conditions.
Banaszewski, Marek, Bot, Emilie, Braun, Fracnois, Celutkiene, Jelena, Chouihed, Tahar, Christ, Michael, Claessens, Yann-Erick, Claret, Pierre-Geraud, Collins, Sean P., Cone, David C., Desmettre, Thibaut, Di Somma, Salvatore, Dunne, Robert B., Dupriez, Florence, Dyani, Mohammed, Escalada, Xavier, Ezekowitz, Justin, Freund, Yonathan, Goldstein, Patrick, Goodloe, Jeffrey M., Gregor, Roman, Guss, David, Hachimi Idrissi, Saïd, Han, Lim Swee, Harjola, Pia, Harjola, Veli-Pekka, Harrell, Andrew J., Hazlitt, Melissa, Hong, Rick, Hoppu, Sanna, Iirola, Timo, Knapp, Joshua M., Korgvee, Ago, Kruse, Nanna, Kuisma, Markku, Kurola, Jouni, Lainscak, Mitja, Laribi, Said, Leach, Robert, Lubin, Jeffrey S., Luk, Jeffrey H., Lund, Vesa, MacNeal, James, Makela, Pekka, Mansour, Cherif, Martikainen, Matti, Martin, Javier, Martin-Sanchez, Francisco J., McKinney, Jared, Mercer, Mary P., Metra, Marco, Meyer, Isabelle, Mimoz, Olivier, Miro, Oscar, Moeckel, Martin, Mols, Pierre, Montassier, Emmanuel, Penaloza, Andrea, Portela, Roberto C., Pruett, Kim, Pumputiene, Vanda, Rekosz, Jerzy, Reuter, Paul-Georges, Ricard-Hibon, Agnes, Rognas, Leif, Rosenberg, Paul, Sandberg, Marten, Swanson, Doug, Tarvasmaki, Tuukka, Tazarourte, Karim, Thys, Frederic, Torronen, Kari, Vannuffelen, Marc, Vermylen, Olivier, Weisberg, Stacy N., Weiss, Dale, Wilen, Susanna, Yee, Allen   +77 more
core   +1 more source

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source

Association of genetic polymorphisms of brain natriuretic peptide with cardiovascular diseases

Российский кардиологический журнал
Currently, natriuretic peptides (including brain natriuretic peptide (BNP)) are widely used in clinical practice as biomarkers for various cardiovascular diseases.
A. Ya. Panarina, G. I. Lifshits
doaj   +1 more source

Low NT-proBNP levels in overweight and obese patients do not rule out a diagnosis of heart failure with preserved ejection fraction [PDF]

, 2018
Background Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous syndrome that presents clinicians with a diagnostic challenge. The use of natriuretic peptides to exclude a diagnosis of HFpEF has been proposed.
Abbate, Antonio, Arena, Ross, Billingsley, Hayley, Buckley, Leo F., Canada, Justin M., Carbone, Salvatore, Del Buono, Marco G., Kadariya, Dinesh, Trankle, Cory R., Van Tassell, Benjamin W.   +9 more
core   +1 more source